Profile
Dr. Charles Conway is a Chief Scientific Officer at Biohaven Pharmaceutical Holding Co. Ltd. Dr. Conway was previously employed as an Associate Director-Biology Analytics by Bristol Myers Squibb Co. He received his undergraduate degree from the University of Central Missouri, a graduate degree from the University of California San Diego and a doctorate degree from the University of California, Santa Barbara.
Former positions of Charles Conway
| Companies | Position | End |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | 02/10/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/2016 |
Training of Charles Conway
| University of Central Missouri | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- Charles Conway
